Searched for
BRISTOL MYERS SQUIBB
In 1944, a retired IRS auditor Anne Scheiber invested $5,000 in stocks; 51 years later, her portfolio was worth $22 millionAnne Scheiber reportedly retired in the mid-1940s with an annual salary of about $3,150. She had never been promoted. Her pay had also chan...30 Sep, 2026, 09.35 PM IST- Anthropic quietly sets up biology lab as it ramps AI drug programAt a time when fears of AI are gripping the public, the startup has built a wet lab, or place for physical experiments, in the San Francisc...18 Sep, 2026, 10.53 PM IST
- 'No discussions' over AstraZeneca-Bristol Myers deal, senior source saysAstraZeneca and Bristol Myers Squibb have denied any ongoing merger discussions. A senior source close to the matter stated no deal was eve...05 Aug, 2026, 06.33 PM IST
- Bristol Myers partners with Microsoft for AI-driven lung cancer detectionBristol Myers Squibb is joining forces with Microsoft. They will use artificial intelligence to find lung cancer earlier. This technology a...20 Jan, 2026, 07.35 PM IST
- Syngene expands research collaboration with Bristol Myers SquibbSyngene International has extended its research partnership with Bristol Myers Squibb until 2035. This expanded agreement covers more servi...19 Jan, 2026, 08.41 PM IST
- Natco Pharma's Canadian unit signs pact with Celgene for cancer treatment drugNatco Pharma entered into an agreement with biopharmaceutical firm Celgene for Lenalidomide capsules, which is used to treat various types ...10 Jul, 2020, 12.48 PM IST
- Biocon arm widens partnership terms with Bristol-Myers SquibbAs part of the expansion, Syngene will set up a new dedicated facility spread across 25,000 sq ft of laboratory and office space for Bristo...14 Nov, 2017, 11.33 AM IST
- Natco Pharma signs agreement for manufacturing, sale of hepatitis C drugDaclatasvir, discovered and developed by Bristol-Myer Squibb, is the first-in-class NS5A inhibitor used in combination with Sofosbuvir to t...21 Jan, 2016, 11.36 AM IST
- Biocon’s unit extends partnership with US-based Bristol-Myers SquibbThe two cos announced to renew their engagement, boosted by encouraging results in last 5 years, during when 6 drug molecules have been bro...04 Jun, 2014, 06.43 PM IST
- Biocon inks pact with Bristol-Myers for insulin drug candidate IN-105Biotechnology major Biocon today said it has entered into an agreement with Bristol-Myers Squibb for it's oral insulin new drug candidate I...16 Nov, 2012, 02.06 PM IST
- Biocon close to oral insulin deal with Bristol-Myers SquibbFour months after its partnership with Pfizer fell through, Biocon is now close to inking a deal with US-based biopharmaceuticals giant Bri...25 Jul, 2012, 02.33 PM IST
- Bristol-Myers Squibb to acquire Amylin for USD 5.3 billionBristol-Myers Squibb will acquire drug maker Amylin for USD 5.3 billion, a move that will strengthen its position in the diabetic medicines...30 Jun, 2012, 07.48 PM IST
- Bristol-Myers offers $3.5 bn for Amylin: ReportsShares of Amylin Pharmaceuticals Inc rose as much as 51 percent as the company rejected a $3.5 billion unsolicited takeover bid from Bristo...28 Mar, 2012, 08.26 PM IST
- Bristol-Myers to sell medical imaging unitDrug developer Bristol-Myers Squibb said on Monday it will sell its medical imaging unit to private equity firm Avista Capital Partners for...19 Dec, 2007, 02.17 AM IST
- Glenmark gets US nod for pravastatin sodiumGlenmark Pharmaceuticals announced on Wednesday that it had received approval in the US to market a generic version of Bristol Myers Squibb...17 May, 2007, 02.55 AM IST
- Syngene signs agreement with Bristol-MyersBiocon’s subsidiary company Syngene said it has entered into a research partnership with Bristol-Myers Squibb.16 Mar, 2007, 03.27 AM IST
- Biocon subsi ties up with Bristol-Myers SquibbIntegrated biotechnology firm Biocon on Wednesday said its subsidiary Syngene has entered into a research partnership with global pharma ma...14 Mar, 2007, 11.00 AM IST
Load More
